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Introduction
•Cardiovascular disease (CVD) is a preventable cause of death
and dietary intake is linked to numerous modifiable risk factors of
CVD (1).
•The individual response to current public health nutrition advice
to reduce the risk of CVD is variable and may be explained by
individual genotype (2).
• Studies have attempted to understand the gene-diet interactions
to reduce CVD risk through dietary modification, with mixed
findings (3,4).
•Two well studied single nucleotide polymorphisms associated
with CVD are the apolipoprotein E (ApoE) gene and the
methylenetetrahydrofolate reductase (MTHFR) gene.
•Some evidence suggests individual response to dietary advice
following genotype information may be more effective in eliciting
dietary change than general dietary advice (5). However, the
effectiveness of personalised nutrition and how it is delivered
remains unclear (6).
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Aim
To determine the effect of genotype (ApoE and MTHFR) and diet (fat and folate) combined or in isolation on intermediate CVD risk factors.
Also, to determine if personalised nutrition advice based on genotype affects dietary change.
Methods
Participants: 115 men and women aged >18 years without coronary
heart disease or stroke/transient ischaemic attack.
Measures:
Genotype: DNA was extracted from a saliva sample. Genotyping for
APOE genotype rs7412 (E2) rs429358 (E4) and MTHFR genotype
C677T rs1801133 was carried out using the TaqMan method.
CVD risk: Estimated using QRISK®2-2017 cardiovascular disease
risk calculator. Total cholesterol : HDL cholesterol was measured
using The CardioChek® Professional Analyser point-of-care test
system. Blood pressure was measured using a Digital Blood
Pressure Monitor.
Dietary intake: Estimated using the Automated Multiple-Pass
Method. Analysed using Nutritics, nutrition analysis software to
determine reported energy, fat and folate intake.
Conclusions
• The preliminary findings from this study suggest there was no effect of genotype (ApoE and MTHFR) and diet (fat and folate) combined or
in isolation on intermediate CVD risk factors.
•Personalised nutrition advice based on genotype does not elicit favourable dietary change, which is in agreement with previous research7.
•Furthermore, in the case of saturated fat intake, personalised dietary advice to participants with a risk associated genotype elicits
unfavourable dietary change.
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Figure 2.  Number of participants, with a risk associated genotype (n = 26), 
meeting recommended saturated fat intake pre and post personalised dietary 
advice based on genotype.
Results
• A two-way MANOVA revealed the interaction effect between genotype and diet on the combined CVD risk factors was not statistically 
significant (F = 0.820, p = 0.555 ). The main effect of genotype on the combined CVD risk factors was not statistically significant, 
(F=0.336, p = 0.962). The main effect of diet on the combined CVD risk factors was not statistically significant (F=0.719, p = 0.635). 
• An exact McNemar’s test revealed the proportion of participants with a risk associated genotype that reported dietary intakes meeting 
recommendations for saturated fat significantly decreased following personalised dietary advice based on their genotype and reported 
intake (p = 0.039).
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